Drug intelligence / Profile preview

Qizhu formula

Development stage
Unknown
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration
Oral
01

Overview

Qizhu formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine and the Shanghai University of Traditional Chinese Medicine. It is specifically investigated for the treatment of triple-negative breast cancer (TNBC) during the perioperative period. The formula is primarily composed of botanical extracts, including *Astragalus membranaceus* (Huangqi) and *Atractylodes macrocephala* (Baizhu), which are traditionally used to tonify Qi and strengthen the spleen. In clinical research, Qizhu formula is evaluated for its potential to improve relapse-free survival (RFS) by modulating the tumor immune microenvironment and enhancing systemic anti-tumor immunity. It is often studied in combination with integrative therapies, such as acupuncture, to reduce the risk of recurrence and improve patient outcomes following surgery.

Other names
Qi-Zhu-FangQizhu decoction

Beyond the preview

Go deeper on Qizhu formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qizhu formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call